FAM
EW icon

Forty4 Asset Management’s Edwards Lifesciences EW Stock Holding History

Forty4 Asset Management’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-61,800
Closed -$10K – 240
2013
Q3 		$10K Buy
+61,800
New +$723K ﹤0.01% 237

Other funds holding EW

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
FC
Fairpointe Capital Chicago, Illinois $66.3M AUM 101.32% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP
Jana Partners New York $1.34B AUM 4.95% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Forty4 Asset Management's EW Position: Q4 2013 in Review

Forty4 Asset Management sold out of Edwards Lifesciences (EW) in Q4 2013, closing a stake of 179,892 shares — an estimated $2.09M sold.

Forty4 Asset Management first reported a position in EW in Q3 2013 and held it in 1 quarter. The position peaked at $2.09M in Q3 2013. 407 funds tracked by Wall St. Rank hold EW as of Q4 2013.

  • Forty4 Asset Management reported no remaining Edwards Lifesciences position as of Q4 2013 after selling out during the quarter.
  • Forty4 Asset Management sold 179,892 Edwards Lifesciences shares in Q4 2013, an estimated $2.09M.
  • Forty4 Asset Management first reported a position in Edwards Lifesciences in Q3 2013 and held it in 1 quarter.
  • Forty4 Asset Management's Edwards Lifesciences position peaked at $2.09M in Q3 2013.
  • 407 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q4 2013.

Based on Forty4 Asset Management's 13F filing for Q4 2013, filed 11 Feb 2014.